As prevalence of CVDs continues to increase, the AHA and AMA have developed the Target BP initiative to improve blood ...
In March, we reported on back-to-back FDA approvals for two treatments in pulmonary arterial hypertension (PAH). In this ...
On an overcast Tuesday in December, Michael Hale stood before a group of students at the Portland Opportunities Industrial ...
A Mendelian analysis supports the idea that hyperuricemia may be an important risk factor for pulmonary arterial hypertension ...
Chinese scientists have found a common hypertension drug could prove potent in treating a rare but highly invasive brain ...
PAH, or pulmonary hypertension, can leave someone breathless even after a short walk, but better drug combinations have ...
People with high blood pressure who slept for shorter durations were more likely to show poor cognitive function and ...
Merck's Winrevair (sotatercept) gains UK approval for PAH treatment. Key trial results highlight significant exercise ...
The differences did not appear to be associated with potential moderating factors like age, sex, or smoking status.
Adequate Sleep Significantly Reduces the Risk of Hypertension in Adolescents Nov. 11, 2024 — Adolescents who meet the recommended guidelines of nine to 11 hours of sleep per day were shown to ...